Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Milan Žegarac"'
Autor:
Marko Buta, Nada Santrac, Milan Zegarac, Merima Goran, Nikola Jeftic, Nevena Savkovic, Jovan Raketic, Saska Pavlovic, Ognjen Zivkovic, Aleksandar Rankovic, Ivan Markovic
Publikováno v:
Diagnostics, Vol 14, Iss 20, p 2326 (2024)
Introduction: Radiation-induced breast angiosarcoma (RIBAS) is a rare adverse event associated with postoperative breast irradiation. The data from the literature indicate that RIBAS occurs in less than 0.3% of patients treated with adjuvant radiothe
Externí odkaz:
https://doaj.org/article/e3f7921eb8c94efeb40c318a596003ce
Autor:
Vladimir Špica, Ivan Pavlović, Damir Jasarovic, Nebojša Mitrović, Dejan Stevanovic, Milan Žegarac, Dragos Stojanovic
Publikováno v:
Materia Medica. 28:432-444
The modern world views include lymphadenectomy as a therapeutic procedure that is an integral part of radical surgery of stomach cancer. It is performed in an attempt to make the malignant surgery more radical. The aim of any surgical procedure is co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::77dc57ed9617aa530547dc20a6fcdfae
https://doi.org/10.5937/matmed1201432s
https://doi.org/10.5937/matmed1201432s
Autor:
Aleksandar Martinovic, Miloš Bracanović, Gordana Pupic, Zorka Inic, Ivana Inic, Momcilo Inic, Miomir Šašić, Milan Žegarac
Publikováno v:
Acta Medica Medianae, Vol 53, Iss 3, Pp 39-41 (2014)
The treatment of metastatic melanoma represents a challenge. Vemurafenib, a selective BRAF kinase inhibitor, is a new medicine against carcinoma. Recently, it has been shown that it raises the survival rate among patients with metastatic melanoma who
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33d14e3730f31d091d22d97b9143e1ef
Autor:
Vladimir, Nikolić, Neda, Nikolic, Tomašević, Zorica, Davorin, Radosavljevic, Marija, Ristic, Jelena, Spasic, Jasna, Stevanovic, Srdjan, Nikolic, Milan, Zegarac
Publikováno v:
In Annals of Oncology June 2014 25 Supplement 2:ii60-ii60
Autor:
Zorka Inic, Milan Zegarac, Momcilo Inic, Ivan Markovic, Zoran Kozomara, Igor Djurisic, Ivana Inic, Gordana Pupic, Snezana Jancic
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 2014, Iss 8, Pp 107-111 (2014)
Externí odkaz:
https://doaj.org/article/1e87ee297c214b5d8a41fedea75ce94a
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 2013, Iss 7, Pp 159-163 (2013)
Externí odkaz:
https://doaj.org/article/4045d68fdb524e8fa888190c59c71fd5
Autor:
Ivana Inić, Momcilo Inić, Zorka Inić, Milan Zegarac, Aleksandar Martinović, Miomir Šašić, Miloš Bracanović, Gordana Pupić
Publikováno v:
Acta Medica Medianae, Vol 53, Iss 3, Pp 39-41 (2014)
The treatment of metastatic melanoma represents a challenge. Vemurafenib, a selective BRAF kinase inhibitor, is a new medicine against carcinoma. Recently, it has been shown that it raises the survival rate among patients with metastatic melanoma who
Externí odkaz:
https://doaj.org/article/5228c4373799444ebccd9d6eee2a08db